MRNA

Moderna Inc

197.63

Oct 22 • 1:00 PM ET -48.18 (-19.60%)

Healthcare Biotechnology USA Large NASD

Today, 12:03 PMNo clear catalyst identified; Moderna falls ahead of Saturday’s pivotal melanoma data release

Peers: BNTX NVAX PCVX ALNY ARCT REGN VALN IONS VIR MRVI

| Held by: VTI QQQ VOO IVV SPY VB VO IBB XLV CGGR

Scroll to Statements

Index	NDX, S&P 500
Market Cap	78.90B
Enterprise Value	75.05B
Income	-3.15B
Sales	2.23B
Book/sh	16.94
Cash/sh	12.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4700
IPO	Dec 07, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	35.41
P/B	11.66
P/C	15.36
P/FCF	-
EV/EBITDA	-
EV/Sales	33.68
Quick Ratio	2.18
Current Ratio	2.29
Debt/Eq	0.19
LT Debt/Eq	0.18
Option/Short	Yes / Yes

EPS (ttm)	-7.98
EPS next Y	-4.77
EPS next Q	-1.11
EPS this Y	-15.98%
EPS next Y	43.37%
EPS next 5Y	27.54%
EPS past 3/5Y	- -29.93%
Sales past 3/5Y	-53.32% 19.33%
EPS Y/Y TTM	-6.22%
Sales Y/Y TTM	-27.62%
EPS Q/Q	7.60%
Sales Q/Q	2.11%
Earnings	Nov 06 BMO
EPS/Sales Surpr.	3.06% 40.87%

Insider Own	8.51%
Insider Trans	-2.51%
Inst Own	80.34%
Inst Trans	2.20%
ROA	-27.43%
ROE	-39.00%
ROIC	-39.41%
Gross Margin	12.57%
Oper. Margin	-149.01%
Profit Margin	-141.43%
SMA20	-5.97%
SMA50	17.41%
SMA200	143.03%
Trades

Shs Outstand	399.00M
Shs Float	365.20M
Short Float	8.45%
Short Ratio	1.59
Short Interest	30.86M
52W High	254.48 -22.34%
52W Low	22.28 787.02%
Volatility	10.80% 8.54%
ATR (14)	20.03
RSI (14)	49.52
Beta	1.20
Rel Volume	1.62
Avg Volume	19.46M
Volume	17,681,892

Perf Week	-16.44%
Perf Month	8.52%
Perf Quarter	265.50%
Perf Half Y	273.94%
Perf YTD	570.15%
Perf Year	636.04%
Perf 3Y	145.80%
Perf 5Y	-39.48%
Perf 10Y	-
Recom	2.93
Target Price	130.68
Prev Close	245.81
Price	197.63
Change %	-19.60%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-26	Downgrade	Citigroup	Neutral → Sell	$80
Sep-03-26	Downgrade	Rothschild & Co Redburn	Neutral → Sell	$81
Aug-28-26	Upgrade	Argus	Hold → Buy	$180
Aug-25-26	Upgrade	Wolfe Research	Underperform → Peer Perform
Aug-19-26	Upgrade	William Blair	Mkt Perform → Outperform
Aug-19-26	Upgrade	BofA Securities	Underperform → Neutral
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70

Show Previous Ratings

Today 08:22AM	Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data. (MarketWatch) -19.60%
12:01AM	Why Did MRNA, CVX, V Stocks Jump To 52-Week Highs Today? (Stocktwits)
Oct-21-26 04:59PM	7 healthcare stocks that stand out as investors pay up for the sector (MarketWatch)
05:30AM	Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market (The Wall Street Journal)
Oct-20-26 05:14PM	Dow outperforms as Wall Street rises, healthcare stocks lead gains (Reuters) +6.69%
04:35PM	Loading…
04:35PM	OpenAI acquires startup Orchestra Bio to beef up its biotech business (TechCrunch)
02:41PM	The Healthcare Sector Nears a New High. These Stocks Are Leading the Charge. (Barrons.com)
02:35PM	OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports (Investing.com)
01:08PM	Healthcare sector rallies to record high, even with the broad market gains (MarketWatch)
Oct-18-26 11:15PM	Stocktwits Pharma Pulse: Moderna-Merck Cancer Vaccine Grabs Spotlight As Kidney-Cancer And MS Data Pour In (Stocktwits)
Oct-16-26 03:36PM	Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather (Barrons.com) -7.82%
11:22AM	Moderna stock sinks as Wall Street turns cautious following blistering rally (Yahoo Finance)
10:44AM	What Is The Case For Waiting On Moderna Stock? (Trefis)
09:15AM	This week in charts: Modernas massive stock run (BioPharma Dive)
Oct-15-26 11:18PM	Why Did MRNA, KO, V Stocks Climb To 52-Week Highs Today? (Stocktwits)
03:42PM	Loading…
03:42PM	MRNA Stock Hits Fresh 52-Week Highs As Goldman Raises Target Ahead Of Melanoma Vaccine Data (Stocktwits)
Oct-14-26 09:46AM	Verastem Is Getting a New CEO, $250 Million, and a Shot at Another Cancer Drug (Barrons.com)
Oct-13-26 07:00AM	Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026 (ACCESSWIRE)
Oct-12-26 10:23PM	Moderna Stock Soared 14% as NIH Plans COVID-Style Push for Cancer Vaccines (TIKR) -5.00%
05:01PM	Where Could Moderna's Next Growth Come From? (Trefis)
01:33PM	Moderna stock surges more than 600% in 2026 (Quartz)
09:42AM	Tech slumps as oil prices rise, focus turns to earnings season kickoff: AlphaCheck (Yahoo Finance)
09:04AM	Moderna Stock Has Been on a Winning Streak (The Wall Street Journal)
05:01AM	Stock Market Today: Diesel Prices Slip on Trump Push for Russia-Ukraine Truce (The Wall Street Journal)
Oct-11-26 11:03PM	Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week? (Stocktwits)
Oct-10-26 06:23PM	A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year (BeInCrypto)
09:19AM	Flu season is already here. Here's what to know about this year's flu shots. (MarketWatch)
Oct-09-26 08:09PM	BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push (Stocktwits) +14.21% -5.00%
04:23PM	MRNA Stock Sets New 52-Week High As Nasdaq-100 Reentry Meets NIH Cancer-Vaccine Push (Stocktwits)
04:13PM	Moderna stock hits 4-year high on planned national cancer vaccine effort (Yahoo Finance)
12:14PM	Loading…
12:14PM	Moderna stock jumps on planned national cancer vaccine effort (Yahoo Finance)
Oct-07-26 04:19PM	Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets (Investopedia)
10:43AM	CPHI 2026: Moderna builds on its COVID-era manufacturing lessons (Pharmaceutical Technology)
06:26AM	Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility (InvestorsHub)
Oct-06-26 05:04PM	Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare. (Barrons.com) -7.75%
04:48PM	Novavax, Moderna stocks fall after WHO calls plague risk 'low' (Yahoo Finance)
04:38PM	Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers (Investor's Business Daily)
Oct-05-26 11:34PM	NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards' (Stocktwits) +6.95%
07:42PM	NVAX Stock Outruns Moderna As Vaxcytes Shot Clears A Late-Stage Test (Stocktwits)
03:30PM	MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns (Stocktwits)
12:01AM	Grail Jumps as Cancer Test Nears Market (The Daily Upside)
Oct-03-26 02:31PM	Merck Stock Is Up 61% in a Year. Is There Room Left to Run? (TIKR)
Oct-02-26 06:43AM	Warner Bros. Stock Is About to Leave the Nasdaq. Here's What's Replacing It. (Barrons.com)
05:51AM	Nike, ON Semi, Moderna, and More Stocks That Explain Today's Market (Barrons.com)
04:31AM	Nasdaq, S&P 500, Dow Futures Rise Ahead Of Jobs Report: NKE, META, RKLB, MRNA, SLS, TSLA Stocks In Focus (Stocktwits)
03:02AM	SLS, IBRX Stocks Climb Overnight: Retail Eyes Modernas Rally As MRNA Lands A Nasdaq-100 Spot (Stocktwits)
Oct-01-26 12:21PM	After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move (Investor's Business Daily)
08:03AM	Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz (Investor's Business Daily)
03:18AM	Everpure Stock Is Septembers Surprise S&P 500 Winner, Surging More Than 40% As Retail Piles In (Stocktwits)
Sep-30-26 05:09PM	Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today's Market (Barrons.com) -5.35%
04:12PM	After Moderna's Dizzying Rally, It's Time To Sell, Says Analyst (Investor's Business Daily)
03:31PM	Moderna Stock Slumps as Citi Says Its Time to Sell After 500% Rally This Year (Investopedia)
11:28AM	Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter (Barrons.com)
10:59AM	Citi tells investors it's time to sell Moderna after 600%-plus stock gains (MarketWatch)
10:49AM	Moderna Shares Tumble After Citi Delivers Stark Sell Rating (GuruFocus.com)
09:41AM	Tech leads stocks higher after cooler-than-expected inflation read: AlphaCheck (Yahoo Finance)
09:40AM	Target upgraded, Moderna downgraded: Wall Street's top analyst calls (The Fly)
08:03AM	MRNA Stock Falls Premarket After Citi Downgrade: Analyst Says Valuation Looks Stretched Despite Cancer Vaccine Momentum (Stocktwits)
08:02AM	Premarket movers: Micron; Boeing rises, Moderna slides (Investing.com)
07:42AM	Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded It to Sell. (Barrons.com)
07:00AM	Moderna Adds Chief Operating Officer Role as Company Expands into Oncology (ACCESSWIRE)
Sep-28-26 06:29AM	Intel's stock drops as AI fears mount, and other early market movers (MarketWatch)
03:59AM	MRNA Stock Eyes Best Year Ever: Analyst Calls Chinas AI Drug Lead Baseless As Moderna Awaits Cancer Data (Stocktwits)
03:37AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to fall after Trump rejects Iran offer; Oil climbs, Treasury yields jump; Nvidia stock rises (MarketWatch)
12:47AM	Why Did AMD, HPE, MRNA Stocks Surge To 52-Week Highs Last Week? (Stocktwits)
Sep-27-26 08:46AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
Sep-25-26 02:37PM	MRNA, PGEN Stocks Hit Multi-Year Highs Whats Driving The Momentum Today? (Stocktwits)
11:39AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
01:07AM	Moderna Stock Jumped 7% Thursday. The Real Test Comes at ESMO on October 24. (TIKR)
Sep-24-26 11:23PM	MRNA On Track To Be September's No. 2 S&P 500 Stock But These 5 Smaller Health Care Names Did Even Better (Stocktwits) +6.98%
06:41PM	From $63 To $195: Modernas Two-Month Rerating Isnt Done (Stocktwits)
Sep-23-26 11:52PM	Why Did META, MRNA, OKTA Stocks Surge To 52-Week Highs Today? (Stocktwits)
01:54PM	These 2 Stocks Are Bucking The Broader Market Selloff To Hit New Multi-Year Highs Heres Whats Driving The Enthusiasm (Stocktwits)
12:53PM	Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker Is Going Next (Barrons.com)
08:28AM	6 'Moonshot' Biotech Stocks That Offer Big Risks, Bigger Rewards (Barrons.com)
01:45AM	These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right. (Barrons.com)
Sep-22-26 01:39PM	Was Moderna Stock's Cancer Vaccine Run Visible In Advance? (Trefis) +5.56%
03:33AM	Moderna Stock Jumped 12% Yesterday. An ESMO Presidential Slot Explains Why. (TIKR)
Sep-21-26 11:39PM	Why Did AMD, WBD, MRNA Stocks Surge To 52-Week Highs Today? (Stocktwits) +12.27%
03:43PM	Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters. (MarketWatch)
01:40PM	Moderna To Present Additional Data From Key Melanoma Trial At ESMO Congress Retail Says Breakout Is Getting Hard To Ignore (Stocktwits)
01:12PM	Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test. (Barrons.com)
10:12AM	Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026 (ACCESSWIRE)
03:00AM	Modernas Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinsons drug (Fortune)
Sep-20-26 05:14PM	3 Bullish Setups for the Week Ahead (Zacks)
Sep-18-26 08:27AM	One stock is up 540%, and it's not alone (GuruFocus.com)
08:03AM	Dow Jones Futures: After S&P 500, Nasdaq Rebound, What's Next? Moderna, AMD, SpaceX Flash Buy Signals. (Investor's Business Daily)
Sep-17-26 03:52PM	Will 2026 Doom and Gloom Lead to Opportunity? (Zacks) +8.55%
12:32PM	Moderna: Another Day, Another Big Stock Move. Is the Cancer Vaccine Rally Back On? (Barrons.com)
03:21AM	This Tiny Biotech Is Beating MRNA, IOVA And SLS Here's How A Billionaire Fueled Its September Rally (Stocktwits)
Sep-14-26 10:00AM	AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 (PR Newswire)
Sep-13-26 04:34PM	Dow Jones Futures: Will Anthropic-Led Call For Slowdown Hit AI Stocks? Fed Meeting Aheadan, SpaceX's Musk Call For AI Slowdown (Investor's Business Daily)
Sep-11-26 04:40PM	How Cathie Wood's Fund Gave Us A Back Door To Moderna's Breakthrough (Investor's Business Daily) +5.38%
Sep-10-26 05:17AM	mRNA cancer vaccines biggest barriers to market (Pharma Voice)
Sep-08-26 04:50PM	AI, Cancer Vaccines, and Next-Gen Medicine (Zacks)
Sep-07-26 09:49PM	The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI (BeInCrypto)
Sep-04-26 06:10AM	GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says (Proactive)
Sep-03-26 01:39PM	Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense (Barrons.com)
11:10AM	Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating (Barrons.com)
09:31AM	Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls (The Fly)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoge Stephen	President	Oct 14 '26	Option Exercise	12.21	76,453	933,491	1,638,482	Oct 16 04:09 PM
Hoge Stephen	President	Oct 15 '26	Option Exercise	12.21	76,452	933,479	1,675,710	Oct 16 04:09 PM
Hoge Stephen	President	Oct 15 '26	Sale	220.72	39,145	8,640,084	1,636,565	Oct 16 04:09 PM
Hoge Stephen	President	Oct 14 '26	Sale	213.48	39,224	8,373,453	1,599,258	Oct 16 04:09 PM
Hoge Stephen	Officer	Oct 15 '26	Proposed Sale	220.72	39,145	8,640,033		Oct 15 10:32 AM
Hoge Stephen	Officer	Oct 14 '26	Proposed Sale	213.48	39,224	8,373,519		Oct 14 09:58 AM
Hoge Stephen	President	Sep 14 '26	Option Exercise	12.21	76,453	933,491	1,566,152	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Option Exercise	12.21	76,452	933,479	1,602,310	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Sale	146.07	40,281	5,883,846	1,562,029	Sep 16 04:48 PM
Hoge Stephen	President	Sep 14 '26	Sale	144.13	40,294	5,807,574	1,525,858	Sep 16 04:48 PM
Hoge Stephen	Officer	Sep 15 '26	Proposed Sale	146.07	40,281	5,883,709		Sep 15 10:46 AM
Mock James M	Chief Financial Officer	Sep 10 '26	Option Exercise	30.96	19,836	614,123	94,211	Sep 14 04:25 PM
Mock James M	Chief Financial Officer	Sep 10 '26	Sale	134.49	34,836	4,685,094	59,375	Sep 14 04:25 PM
Hoge Stephen	Officer	Sep 14 '26	Proposed Sale	144.13	40,294	5,807,746		Sep 14 02:39 PM
Mock James M	Officer	Sep 10 '26	Proposed Sale	134.49	34,836	4,685,094		Sep 10 10:14 AM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Option Exercise	30.96	3,471	107,462	77,600	Sep 03 04:56 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Sale	139.95	3,471	485,766	74,129	Sep 03 04:56 PM
Klinger Shannon Thyme	Officer	Sep 01 '26	Proposed Sale	139.95	3,471	485,766		Sep 01 11:22 AM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Option Exercise	19.15	499,246	9,560,561	6,687,037	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 06 '26	Option Exercise	19.15	252,469	4,834,781	6,440,260	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Sale	57.52	499,246	28,715,011	6,187,791	Aug 07 04:11 PM
Bancel Stephane	Officer	Aug 05 '26	Proposed Sale	58.00	499,246	28,956,268		Aug 05 01:02 PM
Hoge Stephen	President	Jul 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jul 16 04:45 PM
Hoge Stephen	President	Jul 15 '26	Sale	67.60	53,336	3,605,514	1,483,848	Jul 16 04:45 PM
Hoge Stephen	Officer	Jul 15 '26	Proposed Sale	67.60	53,336	3,605,514		Jul 15 10:22 AM
SAGAN PAUL	Former Director	Jun 18 '26	Proposed Sale	64.57	25,770	1,663,875		Jun 18 03:26 PM
Hoge Stephen	President	Jun 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jun 17 04:10 PM
Hoge Stephen	President	Jun 15 '26	Sale	51.37	53,336	2,739,870	1,483,848	Jun 17 04:10 PM
Hoge Stephen	Officer	Jun 15 '26	Proposed Sale	51.37	53,336	2,739,870		Jun 15 11:43 AM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Option Exercise	30.96	3,471	107,462	70,939	Jun 08 04:34 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Sale	50.00	3,471	173,550	67,468	Jun 08 04:34 PM
Klinger Shannon Thyme	Officer	Jun 04 '26	Proposed Sale	50.00	3,471	173,550		Jun 04 01:26 PM
AFEYAN NOUBAR	Director	May 21 '26	Option Exercise	19.15	9,263	177,386	13,187	May 22 07:00 PM
AFEYAN NOUBAR	Director	May 21 '26	Sale	46.84	9,263	433,879	3,924	May 22 07:00 PM
Flagship Pioneering, LLC	Affiliate	May 21 '26	Proposed Sale	46.84	9,263	433,880		May 21 03:06 PM
Hoge Stephen	President	May 15 '26	Option Exercise	19.15	53,336	1,021,384	1,531,333	May 18 04:57 PM
Hoge Stephen	President	May 15 '26	Sale	48.40	53,336	2,581,462	1,477,997	May 18 04:57 PM
Hoge Stephen	Officer	May 15 '26	Proposed Sale	48.40	53,336	2,581,462		May 15 09:47 AM
SAGAN PAUL	Former Director	May 08 '26	Proposed Sale	54.48	36,759	2,002,787		May 08 11:24 AM
Hussain Abbas	Director	May 01 '26	Sale	46.63	5,682	264,952	12,066	May 04 05:25 PM
Hussain Abbas	Director	May 01 '26	Proposed Sale	46.63	5,682	264,952		May 01 11:44 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Stephane Bancel M.B.A.

PresidentDr. Stephen Hoge M.D.

Chief Financial OfficerMr. James M. Mock

Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger J.D.

Chief Operating OfficerMr. Juan Andres

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your Finviz experience